ArticleViewAbstractPharmacognosy Journal,2023,15,5,905-909.DOI:10.5530/pj.2023.15.172Published:October 2023Type:Research ArticleGeneration of Multinucleated Giant Cells due to Leishmania (V.) braziliensis InfectionJesús Rojas-Jaimes, and Luis Castañeda Pelaez Jesús Rojas-Jaimes1,2,*, Luis Castañeda Pelaez1 1Facultad de Ciencias de la Salud, Universidad Privada del Norte, Lima, PERÚ. 2Escuela de Medicina Humana, Universidad Científica del Sur, Lima, PERÚ. Abstract:Background: Multinucleated giant cells were first described by Langhans(MGCs), these MGCs have a role in innate immunity that includes extracellular matrix remodeling associated with granuloma formation; another function of them is to participate in the removal of cellular debris in apoptosis during certain infections. Objective: Generate multinucleated giant cells due to Leishmania (V.) braziliensis infection. Methods: For infection macrophage/parasite ratio of 1 to 10 using the RAW 264.7-line (5 x105/mL) and Leishmania (V.) braziliensis metacyclic promastigotes (50 x105/mL) was a strain maintained in culture Schneider liquid medium, supplemented with 20% fetal bovine serum and 10 000 U/10 mg/mL penicillin streptomycin at pH 7 and 25 °C in the laboratory. Incubation was continued for 4 days, and microscopic observation at 1000X was performed at 24 hours and 96 hours, respectively. Results: In our study an MGC conversion was observed at 96 hours (50% ± 28.2). Conclusions: In vitro MGC model could be used to study the physiopathology of MGC generation by Leishmania (V.) braziliensis infection. Keywords:Immunity, Infection, Leishmania (V.) braziliensis, Macrophage, Multinucleated Giant CellsView:PDF (400.82 KB) PDF Images On top, RAW264.7 macrophages infected with Leishmania (V.) braziliensis at 24 hours showing mononuclear cells in 3 fields (100X). ‹ Effectiveness of the Aedes aegypti Mosquito Vector Control Program in Southeast Asia – A Systematic Review up The Analysis of Matrix Metalloproteinase-9 and Tissue Inhibitor Matrix Metalloproteinase-1 Levels in the Amniochorion Membrane Patients on Premature Rupture of Membranes ›